MedCity News December 13, 2020
Healthcare consumers are increasingly aware of specific therapies in development or on the market that can help treat the diseases they or their loved ones may be suffering from — and this growing awareness is changing the precision medicine arena.
Though the healthcare industry has been upended by the Covid-19 pandemic, investment in the precision medicine sector appears to be healthy, with high valuations and more generalist investor interest in the area than ever before, experts at a MedCity INVEST Precision Medicine panel said. But several trends, including growing consumer awareness, are changing the precision medicine landscape and impacting investing in this sector.
Whether its databases of drug trials, or other educational outlets, patients and their loved ones are increasingly...
Today's Sponsors
Today's Sponsor